biliary biopsy
Procedurebiliary biopsy through a percutaneous approach during a percutaneous biliary drainage
NCT Number: NCT06039670
To evaluate during a 7 months period the efficacy, safety and accuracy of percutaneous transluminal forceps biopsy combined with transhepatic biliary drainage in patients with biliary stricture
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Biological parameters of liver function, histopathology of specimens, comparison with others clinical and pathological data (imaging follow up, percutaneous biopsy, surgical biopsy, endoscopic biopsy) were recorded Comparison between pathological findings of surgery or endoscopy or percutaneous biopsy and specimens coming from biliary forceps biopsy follow up of the patient 12 months after biopsy Evaluation of complications, accuracy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
biliary biopsy through a percutaneous approach during a percutaneous biliary drainage
Time frame: 7 days
Efficacy of PTBD : bilirubinemia after PTFB at Day 7
Time frame: from baseline up to 1 month
Accuracy of PTFB : percentage of true positive and true negative results by pathologists
Time frame: up to 1 month after procedure
Number of patients with PTFB related adverse-events as assessed by Society of Interventional Radiology Standards of Practice Committee classification
University Hospital, Caen
Other
Percutaneous Transluminal Forceps Biopsy Combined With Transhepatic Biliary Drainage in the Management of Patients With Obstructive Jaundice: Efficacy, Safety and Accuracy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03504293
Biliary Stricture, Biliary Tract Diseases
Gothenburg, Sweden
View Trial DetailsNCT01512563
Biliary Stricture, Malignant Neoplasms
Cheonan, South Korea
View Trial DetailsNCT04572711
Adenocarcinoma, Biliary Stricture
Rochester, Minnesota, United States
View Trial DetailsNCT05826639
Bile Duct Diseases, Biliary Stricture
Rochester, Minnesota, United States
View Trial Details